0001842952-23-000006.txt : 20230118 0001842952-23-000006.hdr.sgml : 20230118 20230118160419 ACCESSION NUMBER: 0001842952-23-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lehr Martin A. CENTRAL INDEX KEY: 0001861989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40654 FILM NUMBER: 23534440 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863738787 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 4 1 wf-form4_167407584583579.xml FORM 4 X0306 4 2023-01-17 0 0001842952 Context Therapeutics Inc. CNTX 0001861989 Lehr Martin A. 2001 MARKET STREET SUITE 3915, UNIT #15 PHILADELPHIA PA 19103 1 1 0 0 Chief Executive Officer Common Stock 2023-01-17 4 P 0 6783 0.7364 A 129366 D Common Stock 820190 I Martin Lehr 2000 Trust The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022. The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. /s/ Alex Levit, Attorney-in-Fact 2023-01-18